Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...
The Federal Government has approved the introduction of mandatory pre-employment drug testing for prospective applicants into the Public Service. A statement on Monday by the Director of Information ...
Earlier in December 2025, Recursion Pharmaceuticals reported positive Phase 1b/2 TUPELO trial data for REC-4881 in familial adenomatous polyposis, showing rapid and durable reductions in polyp burden ...
When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
New system to ensure wage protection for Saudi domestic workers Dubai: Saudi Arabia will begin enforcing a mandatory system for paying the salaries of all domestic workers through official electronic ...
Mandatory registration of mobile devices imported into Russia in a single database of IMEI numbers (unique numbers assigned by manufacturers to each device) is planned to be carried out for an ...
Syracuse, N.Y. -- The Onondaga County Water Authority has now issued mandatory water restrictions in six Central New York towns as impacts from a busted water line in Cicero become apparent. Manlius ...
SINGAPORE: Scammers, as well as recruiters and members of scam syndicates, will face mandatory caning of at least six strokes under amendments to Singapore's criminal law set to take effect on Dec 30.
Generative AI is now embedded in legal research and drafting, but its rapid adoption has led to unintended and increasingly serious consequences for courts: a growing volume of hallucinated cases, ...
The government has confirmed two categories of NDIS providers will soon be subject to mandatory registration, after sitting on recommendations for more than a year. Mandatory provider registration has ...
JPMorgan upgraded Recursion Pharmaceuticals (RXRX) to Overweight from Neutral with a price target of $11, up from $10. The firm says the company’s REC-4881 has shown “strong and durable” efficacy in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback